Eblasakimab
「Eblasakimab」熱門搜尋資訊
「Eblasakimab」文章包含有：「Eblasakimab」、「EblasakimabMonthlyDosingShowsPotentialforBest」、「Eblasakimab,anovelIL」、「Eblasakimab」、「StudyofEblasakimabinMaleorFemaleModerate」
查看更多
Eblasakimab
https://aslanpharma.com
Eblasakimab is a novel, fully human, monoclonal IgG4 antibody that binds specifically to the Interleukin (IL)-13 receptor, preventing signaling of IL-4 and ...
Eblasakimab Monthly Dosing Shows Potential for Best
https://aslanpharma.com
Eblasakimab is the first biologic in moderate-to-severe atopic dermatitis to demonstrate a competitive efficacy profile with once-monthly ...
Eblasakimab, a novel IL
https://pubmed.ncbi.nlm.nih.go
Eblasakimab is a first-in-class monoclonal antibody under investigation for the treatment of atopic dermatitis (AD), which targets IL-13Rα1, a subunit of ...
Eblasakimab
https://www.sciencedirect.com
Eblasakimab is a first-in-class monoclonal antibody under investigation for the treatment of atopic dermatitis (AD), which targets IL-13Rα1, a subunit of ...
Study of Eblasakimab in Male or Female Moderate
https://clinicaltrials.gov
Study of Eblasakimab in Male or Female Moderate-to-Severe Atopic Dermatitis Patients Previously Treated With Dupilumab ; ASLAN Investigative Site ...